PRC Clinical Completes Over 800 Monitoring Visits In Global Phase 2b Neurology Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--PRC Clinical™, a full-service Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, today announced the completion of over 800 monitoring visits in a global Phase 2b neurodegenerative disease study. The study enrolled more than 700 patients in 73 clinical study sites across 8 countries.

The company provided dedicated trial oversight, site management and monitoring for 56 research centers in the US and Canada including global central laboratory services as well as physical and electronic platform trial master file support.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC